CS
Pavel Šácha

Pavel Šácha

mail pavel.sachainvalid-email-name@invalid-email-domainuochb.cas.cz
phone +420 220 183 452
Group leader
IOCB Compound Library
Pavel Šácha Group
Scientist
Jan Konvalinka Group
Proteases of Human Pathogens
All publications

Latest publications

Re-emerging Aspartic Protease Targets: Examining Cryptococcus neoformans Major Aspartyl Peptidase 1 as a Target for Antifungal Drug Discovery
R. Kryštůfek P. Šácha J. Starková J. Brynda M. Hradilek E. Tloušťová J. Grzymska W. Rut M. J. Boucher M. Drag P. Majer M. Hájek P. Řezáčová H. D. Madhani C. S. Craik J. Konvalinka
Journal of Medicinal Chemistry 64 (10): 6706–6719 (2021)
Go to the publication arrow
The efficiency of insulin production and its content in insulin-expressing model β-cells correlate with their Zn2+ levels
P. Dzianová S. Asai M. Chrudinová L. Kosinová P. Potalitsyn P. Šácha R. Hadravová I. Selicharová J. Kříž J. P. Turkenburg A. M. Brzozowski J. Jiráček L. Žáková
Open Biology 10 (10): 200137 (2020)
Go to the publication arrow
Identification of Novel Carbonic Anhydrase IX Inhibitors Using High-Throughput Screening of Pooled Compound Libraries by DNA-Linked Inhibitor Antibody Assay (DIANA)
J. Tykvart V. Navrátil M. Kugler P. Šácha J. Schimer A. Hlavačková L. Tenora J. Zemanová M. Dejmek V. Král M. Potáček P. Majer U. Jahn J. Brynda P. Řezáčová J. Konvalinka
SLAS Discovery 25 (9): 1026-1037 (2020)
Go to the publication arrow
Optimization of norbornyl‐based carbocyclic nucleoside analogs as cyclin‐dependent kinase 2 inhibitors
C. Köprülüoglu M. Dejmek M. Šála H. Ajani H. Hřebabecký J. Fanfrlík R. Jorda M. Dračínský E. Procházková P. Šácha V. Kryštof P. Hobza M. Lepšík R. Nencka
Journal of Molecular Recognition 33 (8): e2842 (2020)
Go to the publication arrow